THEMIS MEDICARE
Back to Balance Sheet
|
THEMIS MEDICARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹8.83 Cr | ₹7.39 Cr | ₹6.94 Cr | ₹6.47 Cr | ₹0.95 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of THEMIS MEDICARE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹8.83 Cr |
| Mar2024 | ₹7.39 Cr |
| Mar2023 | ₹6.94 Cr |
| Mar2022 | ₹6.47 Cr |
| Mar2021 | ₹0.95 Cr |
How is Deferred Tax Assets / Liabilities of THEMIS MEDICARE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.83 Cr | 19.45 | |
| Mar2024 | ₹7.39 Cr | 6.51 | |
| Mar2023 | ₹6.94 Cr | 7.25 | |
| Mar2022 | ₹6.47 Cr | 582.70 | |
| Mar2021 | ₹0.95 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹843.9 Cr | 1.7% | 9.7% | -55.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | 1.7% |
9.7% |
-55.2% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses